SCHEMBL25167694

SCHEMBL25167694

O=C(O)c1ccc(Nc2nccn3c(-c4ccc(OC(F)F)c(F)c4F)cnc23)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 13/20 0.47
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CCNB2 O95067 1/20 0.37
▸ CCNE2 O96020 1/20 0.37
▸ NTRK1 P04629 1/20 0.37
▸ INSR P06213 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ PRKACA P17612 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ PRKACG P22612 1/20 0.37
▸ PRKACB P22694 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ MAPK3 P27361 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ NTRK2 Q16620 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22123969 0.90 PTK6 (0.48) PTK6ALDH1A1KDM4ECCNB2CCNE2
SCHEMBL30385303 0.90 PTK6 (0.48) PTK6ALDH1A1KDM4ECCNB2CCNE2
SCHEMBL30385313 0.89 PTK6 (0.38) PTK6MAPTNPC1RAB9AMAPKAPK5
SCHEMBL22123325 0.89 PTK6 (0.38) PTK6MAPTNPC1RAB9AMAPKAPK5
SCHEMBL30385589 0.86 PTK6 (0.45) PTK6ALDH1A1KDM4ECCNB2CCNE2
Hydrochloric Acid SCHEMBL25176002 0.86 PTK6 (0.45) PTK6ALDH1A1KDM4ECCNB2CCNE2
Trifluoroacetic Acid SCHEMBL25170318 0.85 PTK6 (0.61) PTK6LCKAURKB
Trifluoroacetic Acid SCHEMBL28982169 0.85 PTK6 (0.39) PTK6NTRK1MAPTNPC1NFKB1
SCHEMBL25173624 0.84 PTK6 (0.51) PTK6LCKAURKB
SCHEMBL22139107 0.84 PTK6 (0.47) PTK6TTKLCKAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230141600-A1 IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-05-11 — — US disclosed
EP-4161931-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-04-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141600-A1 IMIDAZOPYRAZINE DERIVATIVES IKZF3, RRP15, IK PTK6 925/4885ALDH1A1 3337/4885KDM4E 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback